CLEC-2 expression is maintained on activated platelets and on platelet microparticles

Blood

Volumn 124, Issue 14, 2014, Pages 2262-2270

  Gitz, Eelo ^a   Pollitt, Alice Y ^a   Gitz Francois, Jerney J ^a   Alshehri, Osama ^a   Mori, Jun ^a   Montague, Samantha ^a   Nash, Gerard B ^a   Douglas, Michael R ^a,b   Gardiner, Elizabeth E ^c   Andrews, Robert K ^c   Buckley, Christopher D ^a   Harrison, Paul ^a   Watson, Steve P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C TYPE LECTIN LIKE RECEPTOR 2; FC RECEPTOR IIA; GLYCOPROTEIN VI; MONOCLONAL ANTIBODY; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG; CLEC2B PROTEIN, HUMAN; FC RECEPTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIB; LECTIN; MEMBRANE PROTEIN; PLATELET MEMBRANE GLYCOPROTEIN VI; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MEGAKARYOCYTE; PLATELET MICROPARTICLE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; ANIMAL; CHEMISTRY; CYTOLOGY; INFLAMMATION; METABOLISM; MOUSE; THROMBOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; BLOOD PLATELETS; HUMANS; INFLAMMATION; LECTINS, C-TYPE; MEGAKARYOCYTES; MEMBRANE GLYCOPROTEINS; MICE; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEIN IIB; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, IGG; RECOMBINANT PROTEINS;

EID: 84907688341     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-05-572818     Document Type: Article

References (64)

1. Jackson SP. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med. 2011;17(11): 1423-1436.
2. Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Platelets at work in primary hemostasis. Blood Rev. 2011;25(4):155-167.
3. McKenzie SE, Taylor SM, Malladi P, et al. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol. 1999;162(7): 4311-4318.
4. Stolla M, Stefanini L, Andŕe P, et al. CalDAGGEFI deficiency protects mice in a novel model of Fcg RIIA-mediated thrombosis and thrombocytopenia. Blood. 2011;118(4): 1113-1120.
5. Urbanus RT, van der Wal DE, Koekman CA, et al. Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Iba and Fc RIIa in immune thrombocytopenia. Haematologica. 2013;98(7):e70-e72.
6. Warkentin TE, Greinacher A, Gruel Y, Aster RH, Chong BH; scientific and standardization committee of the international society on thrombosis and haemostasis. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost. 2011;9(12): 2498-2500.
7. Tilley DO, Arman M, Smolenski A, et al. Glycoprotein Iba and FcgRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis. J Thromb Haemost. 2013; 11(5):941-950.
8. Arman M, Krauel K, Tilley DO, et al. Amplification of bacteria-induced platelet activation is triggered by FcgRIIA, integrin aIIbb3, and platelet factor 4. Blood. 2014;123(20):3166-3174.
9. Mitrugno A, Williams D, Kerrigan SW, Moran N. A novel and essential role for FcgRIIa in cancer cellinduced platelet activation. Blood. 2014;123(2): 249-260.
10. Hou TZ, Bystrom J, Sherlock JP, et al. A distinct subset of podoplanin (gp38) expressing F4/801 macrophages mediate phagocytosis and are induced following zymosan peritonitis. FEBS Lett. 2010;584(18):3955-3961.
11. Kerrigan AM, Navarro-Nuñez L, Pyz E, et al. Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2. J Thromb Haemost. 2012;10(3):484-486.
12. Peters A, Pitcher LA, Sullivan JM, et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity. 2011;35(6):986-996.
13. Miyamoto Y, Uga H, Tanaka S, et al. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints. Mol Immunol. 2013; 54(2):199-207.
14. May F, Hagedorn I, Pleines I, et al. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood. 2009;114(16): 3464-3472.
15. Suzuki-Inoue K. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation. J Biochem. 2011;150(2):127-132.
16. Hughes CE, Navarro-NÚñez L, Finney BA, Mourão-͆a D, Pollitt AY, Watson SP. CLEC-2 is not required for platelet aggregation at arteriolar shear. J Thromb Haemost. 2010;8(10): 2328-2332.
17. Bender M, May F, Lorenz V, et al. Combined in vivo depletion of glycoprotein VI and C-type lectinlike receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vasc Biol. 2013;33(5): 926-934.
18. Suzuki-Inoue K, Inoue O, Ding G, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem. 2010;285(32): 24494-24507.
19. Bertozzi CC, Hess PR, Kahn ML. Platelets: covert regulators of lymphatic development. Arterioscler Thromb Vasc Biol. 2010;30(12):2368-2371.
20. Finney BA, Schweighoffer E, Navarro-NÚñez L, et al. CLEC-2 and Syk in the megakaryocytic/ platelet lineage are essential for development. Blood. 2012;119(7):1747-1756.
21. Boulaftali Y, Hess PR, Getz TM, et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest. 2013;123(2):908-916.
22. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagendependent microparticle production. Science. 2010;327(5965):580-583.
23. Bergmeier W, Stefanini L. Platelet ITAM signaling. Curr Opin Hematol. 2013;20(5):445-450.
24. Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost. 2007;5(7):1530-1537.
25. Gardiner EE, Karunakaran D, Arthur JF, et al. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa. Blood. 2008; 111(1):165-174.
26. Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK. Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood. 2004;104(12): 3611-3617.
27. Christou CM, Pearce AC, Watson AA, et al. Renal cells activate the platelet receptor CLEC-2 through podoplanin. Biochem J. 2008;411(1): 133-140.
28. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-324.
29. Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F; The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop [published online ahead of print April 2, 2014]. J Thromb Haemost.
30. Suzuki-Inoue K, Fuller GL, Garćia A, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood. 2006;107(2):542-549.
31. Chaipan C, Soilleux EJ, Simpson P, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol. 2006;80(18):8951-8960.
32. Best D, Senis YA, Jarvis GE, et al. GPVI levels in platelets: relationship to platelet function at high shear. Blood. 2003;102(8):2811-2818.
33. Chen H, Locke D, Liu Y, Liu C, Kahn ML. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem. 2002; 277(4):3011-3019.
34. Burkhart JM, Vaudel M, Gambaryan S, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73-e82.
35. Kelton JG. The pathophysiology of heparininduced thrombocytopenia: biological basis for treatment. Chest. 2005;127(2 Suppl):9S-20S.
36. Arthur JF, Gardiner EE, Matzaris M, et al. Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost. 2005;93(4):716-723.
37. Nazi I, Smith JW, Arnold DM, et al. The association between platelet activation and FcgRIIa proteolysis. J Thromb Haemost. 2011; 9(4):885-887.
38. Horstman LL, Ahn YS. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol. 1999;30(2):111-142.
39. Joop K, Berckmans RJ, Nieuwland R, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost. 2001;85(5):810-820.
40. Berckmans RJ, Nieuwland R, Böing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost. 2001; 85(4):639-646.
41. Flaumenhaft R, Dilks JR, Richardson J, et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood. 2009;113(5):1112-1121.
42. Rank A, Nieuwland R, Delker R, et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res. 2010;126(4):e255-e259.
43. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000;101(8):841-843.
44. Lee YJ, Jy W, Horstman LL, et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res. 1993;72(4):295-304.
45. Hughes M, Hayward CP, Warkentin TE, Horsewood P, Chorneyko KA, Kelton JG. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood. 2000;96(1):188-194.
46. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992;119(4):334-345.
47. Couper KN, Barnes T, Hafalla JC, et al. Parasitederived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog. 2010;6(1):e1000744.
48. Gasper-Smith N, Crossman DM, Whitesides JF, et al. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J Virol. 2008;82(15):7700-7710.
49. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum. 2002;46(6):1498-1503.
50. Colonna M, Samaridis J, Angman L. Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur J Immunol. 2000;30(2): 697-704.
51. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA. 2004; 101(16):6062-6067.
52. Del Rey MJ, Faŕe R, Izquierdo E, et al. Clinicopathological correlations of podoplanin (gp38) expression in rheumatoid synovium and its potential contribution to fibroblast platelet crosstalk. PLoS ONE. 2014;9(6):e99607.
53. Chang CH, Chung CH, Hsu CC, Huang TY, Huang TF. A novel mechanism of cytokine release in phagocytes induced by aggretin, a snake venom C-type lectin protein, through CLEC-2 ligation. J Thromb Haemost. 2010;8(11): 2563-2570.
54. Kerrigan AM, Dennehy KM, Mourão-͆a D, et al. CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J Immunol. 2009;182(7):4150-4157.
55. Mourão-͆a D, Robinson MJ, Zelenay S, et al. CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur J Immunol. 2011;41(10):3040-3053.
56. Acton SE, Astarita JL, Malhotra D, et al. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity. 2012;37(2):276-289.
57. Bender M, Hofmann S, Stegner D, et al. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood. 2010;116(17):3347-3355.
58. Tomlinson MG, Calaminus SD, Berlanga O, et al. Collagen promotes sustained glycoprotein VI signaling in platelets and cell lines. J Thromb Haemost. 2007;5(11):2274-2283.
59. Mori J, Pearce AC, Spalton JC, et al. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. J Biol Chem. 2008;283(51):35419-35427.
60. Carramolino L, Fuentes J, Garćia-Andŕes C, Azcoitia V, Riethmacher D, Torres M. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res. 2010;106(7):1197-1201.
61. Herzog BH, Fu J, Wilson SJ, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013; 502(7469):105-109.
62. Béńezech C, Nayar S, Finney BA, et al. CLEC-2 is required for development and maintenance of lymph nodes. Blood. 2014;123(20):3200-3207.
63. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 1989;84(1):92-99.
64. Sarafian V, Jadot M, Foidart JM, et al. Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cells. Int J Cancer. 1998;75(1):105-111.